Deansgate Chaos 🚗💥
Deansgate, Manchester’s key artery for over 200 years, is now a one-way bottleneck with half its width given to barely-used cycle lanes (unless you’re a Deliveroo rider).
Pat Karney, @patkarney I respect you, but this mess is on your watch. It took me 1 hour 10 mins just to get from Lloyd St to Princess Parkway — to start my journey home.
Tourism won’t sustain this city forever. Commerce — Manchester’s true lifeblood — is suffering, with empty office space multiplying. Today I saw motorists fighting in the street. Total chaos.
Sort it out before it’s too late. Today you are asking people not to drive into Manchester as you know with the Derby and other stuff going on, the city will be choked. Hopefully not to death.
💪if you agree with my sentiments, please like, RT this post and follow if you feel the council are wrong. 💪
When Carole was diagnosed with Lepto-Meningeal Disease (LMD) -#MetastaticBreastCancer that has spread to the lining of the brain - she was terrified. However after treatment with whole brain radiotherapy, she is still working and living an active life two years later. MBC patients like Carole need access not only to drugs but also the latest radiotherapy treatments to keep them surviving and thriving for longer.
Have a read of Carole's blog here https://t.co/RKnmQhfApu
#WhoReallyCares #BreastCancerAwarenessMonth #BCAM #costofliving #severitymodifier #METUPUK #DarkerPink #BusyLivingWithMets #IAmThe31 #waitingroomfeet #BreastCancer #BreastCancerCommunity #BreastCancerJourney #BreastCancerSupport #DyingForACure #EarlyDetectionSavesLives #MetastaticBreastCancerAwareness #SecondaryBreastCancer #SecondarySisters #Stage4NeedsMore #StageIVNeedsMore #AdvancedBreastCancer
The ISSCR is deeply saddened to learn of the passing of Connie Eaves. “Connie was the most wonderful scientist - rigorous, smart, funny, kind, and direct. She was a major influence on many generations of stem cell researchers and will be sorely missed.” https://t.co/OxeBLhnCwu
#AACR2024 is just around the corner, taking place in sunny San Diego!
☀ BOOTH 1219 | Two Poster Presentations 🧪
We’re excited to connect with you and discuss your interests or project needs.
Drop us a DM or email our team: [email protected]#oncology#biomarkers#cro
We should be routinely including patients with active brain Mets or LMD in ADC trials starting in phase 1. More and more evidence of a class effect of ADCs in CNS disease and there is a huge unmet medical need.
Searching for the ultimate tool to advance your IBD and Colitis studies? Look no further!!
➡️ Check out our T-Cell Transfer models https://t.co/oPDGpdYuTk
➡️ and our entire IBD lineup https://t.co/GHnUL3ujoU
#epistem#IBDresearch#IBD#innovation#CRO#ContractResearch
Two yrs after early BC Emma was diagnosed with MBC. As well as drug access inequalities there are inequalities accessing surgeries & radiotherapies.
She had spinal surgery to stabilise her spine.
Bone mets are most common for MBC & account for ~70/80% diagnoses #DisappearingLives
The beautiful presence and life force of @mary_huckle. You’ll never be forgotten. You paved the way for every breast cancer advocate that follows your lead. 🫶@METUPUKorg#DisappearingLives
Leila's MBC was ER+/HER- at that time giving little choice of treatment lines. She was living well until diagnosed with leptomeningeal brain metastasis which progressed quickly & died in 3 wks. Unfortunately MRI brain scans aren't standard for patients with MBC #DisappearingLives
An extremely concerning development.
I have been booked to speak at the Spectator's 'How to fix Britain’s cancer crisis' debate at the Conservative Party Conference for some time.
I was recently informed by the organisers that the sponsor of the event, an NHS supplier, threatened to pull their substantial sponsorship fee unless I was removed from the panel.
With full credit to the Spectator, they refused this blatant attempt at censorship at great financial cost.
I don't pretend, or want, to be the most popular person at NHS HQ. But if, as I suspect, they were involved in the attempted cancellation then that is worrying.
I spent over 40 years in the NHS, a period as the WHO cancer chief and have been involved in the development of cancer infrastructure in almost every country in the world.
They may not like my views, but I think that they're based in enough experience to be worth hearing.
In fact, I've been very careful not to be too forthright on how I feel about how healthcare is delivered in the UK.
That certainly won't be the case from now on.
I also heavily suspect that NHS disdain for my critical opinions has contributed to their refusal to help reopen the Rutherford cancer centre network - capable of helping 20,000 patients a year.
It is all extremely murky.
I am looking forward to speaking at the event tomorrow and outlining how I believe we can fix Britain's cancer crisis.
High on the agenda is eradicating the blasphemy culture surrounding the NHS. It is not a world-beating health service and the longer we lie to ourselves that it is, the more patients will suffer.
Rejected due to "cost-effectiveness estimates". This is about NHS costs. The public need to understand it's about choices and priorities. How much tax would they be willing to pay? Who is an NHS priority? What if this meant an early death for your mum/wife/sister? No easy answer
METUPUK is dismayed by the NICE decision not to recommend the drug Enhertu (trastuzumab deruxtecan), for routine use on the NHS in England for #metastaticbreastcancer in HER2-low patients... Please see our statement via this link https://t.co/1nz2HVxH2G
#EnhertuLowNow